FDA panel supports Moderna booster shot for older adults, people at high risk
High-dose of readily available blood thinner reduces risk of death for moderately ill COVID-19 patients
15 October 2021Biden administration to invest $100 million to ease health worker shortage
15 October 2021FDA panel supports Moderna booster shot for older adults, people at high risk
(HealthDay)—Mirroring a similar recommendation issued last month for the Pfizer COVID-19 vaccine, an expert advisory panel to the U.S. Food and Drug Administration on Thursday recommended a half-dose booster shot of the Moderna vaccine be given to certain recipients six months after their second shot.
